Skip to content

GELAPHAR

Active
Private limited companyfounded 198541 yrs activeKloosterstraat 7, 3798 Voeren, BelgiumKBO/BCE: BE 0426.709.631
Summary

GELAPHAR has been active since 1985 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €437,163 and a net result of €65,242. Equity is growing by ~17.2% per year across the filed fiscal years. Its solvency ranks better than 69% of 11293 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Overview

What they do
Retail sale of pharmaceutical products
NACE 47730Warehousing and support activities for transportation NACE 52310NACE 74203
#4 oldest company in Voeren1 site
How big
€774,089total assets 2025
Staff
1.9 FTE
Equity
€437,163
Profit
€65,242
Financially healthy?
96 Excellent Checked score 2025
Bankruptcy chance 12 m
0.1%
Who decides
Parent
KRAUSCH AURELIE MANAGEMENT · 100%
Accounts 39 d early0 of 2 deeds read
Why 96- Sector Retail trade (NACE 47)+ Liquidity: current ratio 1.69, cash €210,146+ Founded in 1985+ Equity €437,163 (56.5% of total assets)Show the evidence

Checked score

Score 2025
96 / 100
Excellent
Probability in this band: under 0.55%
Better than 70% of its sector peers (NACE 47, micro)
Performance against the sector, not lower risk
Financial strength · tick = 2024
Strong
Solvency 81+5
equity 56.5% of total assets
Liquidity 65+7
short-term debt 40.9% · cash 27.1%
Profitability 79=
return on assets 8.4%
Bankruptcy probability, 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.7% (39,869 companies)
  • Liquidity: current ratio 1.69, cash €210,146 lowers the probability
  • Founded in 1985 lowers the probability for this profile
  • Equity €437,163 (56.5% of total assets) lowers the probability
  • Sector Retail trade (NACE 47) raises the probability
Credit up to €40,000 at 30 days acceptable
Liquidity ample (current ratio 1.69 against 1.43 in 2024; short-term debt: 40.9% and cash: 27.1% of total assets), and 43.5% of the assets are financed with debt.
How it is calculated

The band comes from the bankruptcy probability on a scale of 0 to 100: every 10 points more double the odds of getting through the year without bankruptcy.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Place inside the band: half the bankruptcy probability, half how the company does against its sector peers (NACE 47, micro). Better than this share of them on solvency 70%, liquidity 71%, profitability 70%, growth against the median 70%. That is performance, not lower risk; the band itself always comes from the probability.

Bankruptcy probability: model pd-v3.202610020317, computed on 02-10-2026. The model learns from Belgian bankruptcies and reads the registers, the annual accounts and the gazette.

Ceilings: negative or zero equity, a heavy loss, a special KBO legal situation and a missing filing 59 (two missing 44), an ongoing judicial reorganisation or an ending 24. Financial strength does not count in the score.

Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Liquidity: current ratio 1.69, cash €210,146
In the bankruptcy model this factor lowers the probability.
NBB · annual accounts
lowers risk · Founded in 1985
In the bankruptcy model this factor lowers the probability for this profile.
KBO
lowers risk · Equity €437,163 (56.5% of total assets)
In the bankruptcy model this factor lowers the probability.
NBB · annual accounts
raises risk · Sector Retail trade (NACE 47)
In the bankruptcy model this factor raises the probability.
KBO
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 22-06-2026, 39 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
39 d early
2024
31 d early
2023
37 d early
2022
14 d early
2021
27 d early
2020
40 d early
2019
39 d early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 32 days before the deadline; the sector median for financial year 2024 is on the deadline day, and 47% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 30 June (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Position in the running window
02-10-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage
  1. Annual accounts filedfiscal year 2025 · abbreviated…
  2. Annual accounts filedfiscal year 2024 · full…
  3. Annual accounts filedfiscal year 2023 · full…

Key points

  • Positive: Oldest company in Voerenin the Checked rankings #4 View
  • Positive: Always filed on timeaccounts within the deadline every year 8 years View
  • Positive: 8 profitable years in a rowprofit 2025: €65,242 8 years View
  • Controlled by KRAUSCH AURELIE MANAGEMENT 100% View

By topic

Financials

Fiscal year
2025
Total assets
€774,089
Profit
€65,242
Solvency
56.5%
Total assets▲ 7.1%
Net result
20182025
Go to Financials

Timeline

Events
13
Since
2017
Next accounts
by 31-07-2027
  1. 22-06-2026Annual accounts filed
  2. 30-06-2025Annual accounts filed
  3. 24-06-2024Annual accounts filed
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Retail sale of pharmaceutical productsNACE 47730
Founded
01-01-1985
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.